U.S. Genomics, Inc.

Technologies that allow genetics, functional genomics, and protein analysis to be performed at the single molecule level

U.S. Genomics was established in 1997 by Eugene Chan who started out be developing the The GeneEngine™ Technology Platform for the analysis of DNA. In 2002 the first research version of the platform was produced. The first product was launched in 2004.

John Canepa (CEO)
David Hoey (VP, Business Development)

J. Craig Venter
Gus Lawlor
Enrico Petrillo
Stephen C. Knight
Jason P. Rhodes
James A. Saalfield

J. Craig Venter (Chairman)
Hamilton O. Smith
Robert S. Langer
Donald M. Crothers
Alexander Rich
Louis Kunkel
Steve R. Gullans

12 Gill Street
Suite 4700
Woburn, Massachusetts 01801
USA
Phone: +1-781-937-5550
Fax: +1-781-938-0060

The Trilogy™ 2020 technology, which consists of instrumentation, assays and software, combines microfluidics, optical engineering and labelling to in a complete research system that for the detection of single molecules.